Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120427473 | 12042747 | 3 | F | 2016 | 20160628 | 20160208 | 20160706 | EXP | US-PFIZER INC-2016070716 | PFIZER | 70.00 | YR | F | Y | 78.20000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120427473 | 12042747 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | A527301 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
| 120427473 | 12042747 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 21845 | FILM-COATED TABLET | |||||||||||
| 120427473 | 12042747 | 3 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 0.075 UG, 1X/DAY | 0 | .075 | UG | TABLET | QD | ||||||
| 120427473 | 12042747 | 4 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | UNK, EVERY 4 HOURS AS NEEDED | 0 | NEBULISER SOLUTION | ||||||||||
| 120427473 | 12042747 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 120427473 | 12042747 | 6 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | |||||||
| 120427473 | 12042747 | 7 | C | ELIQUIS | APIXABAN | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | TABLET | BID | |||||||
| 120427473 | 12042747 | 8 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 25 MG, 2X/DAY | 0 | 25 | MG | TABLET | BID | |||||||
| 120427473 | 12042747 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD | |||||||
| 120427473 | 12042747 | 10 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 2 PUFFS AS NEEDED EVERY 4 HRS | 0 | 2 | DF | |||||||||
| 120427473 | 12042747 | 11 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 18 UG, 1X/DAY | 0 | 18 | UG | CAPSULE | QD | |||||||
| 120427473 | 12042747 | 12 | C | DOXYCYCLINE MONOHYDRATE | DOXYCYCLINE | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | TABLET | BID | ||||||
| 120427473 | 12042747 | 13 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | ||||||
| 120427473 | 12042747 | 14 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | ANORO ELLIPTA 62.5 MCG/25 MCG DAILY | 0 | INHALATION POWDER | ||||||||||
| 120427473 | 12042747 | 15 | C | ATIVAN | LORAZEPAM | 1 | UNK, 2X/DAY | 0 | TABLET | BID | |||||||||
| 120427473 | 12042747 | 16 | C | VERAMYST | FLUTICASONE FUROATE | 1 | Nasal | UNK, 1X/DAY | 0 | QD | |||||||||
| 120427473 | 12042747 | 17 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | UNK, 4X/DAY | 0 | TABLET | QID | ||||||||
| 120427473 | 12042747 | 18 | C | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | 2 TABLET BEFORE MEALS ONCE A DAY | 0 | 2 | DF | QD | ||||||||
| 120427473 | 12042747 | 19 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | CAPSULE | ||||||||||
| 120427473 | 12042747 | 20 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK, 1X/DAY | 0 | TABLET | QD | |||||||||
| 120427473 | 12042747 | 21 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 2 DF, 1X/DAY (2 SPRAYS 1X/DAY) | 0 | 2 | DF | QD | ||||||||
| 120427473 | 12042747 | 22 | C | COREG | CARVEDILOL | 1 | 1 DF, 2X/DAY WITH FOOD | 0 | 1 | DF | TABLET | BID | |||||||
| 120427473 | 12042747 | 23 | C | EPINEPHRINE. | EPINEPHRINE | 1 | UNK | 0 | |||||||||||
| 120427473 | 12042747 | 24 | C | DALIRESP | ROFLUMILAST | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | TABLET | QD | |||||||
| 120427473 | 12042747 | 25 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | 2 DF, 1X/DAY (2 SPRAYS 1X/DAY) | 0 | 2 | DF | QD | ||||||||
| 120427473 | 12042747 | 26 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | |||||||
| 120427473 | 12042747 | 27 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | UNK | 0 | |||||||||||
| 120427473 | 12042747 | 28 | C | TESSALON | BENZONATATE | 1 | 100 MG, 3X/DAY | 0 | 100 | MG | CAPSULE | TID | |||||||
| 120427473 | 12042747 | 29 | C | CROMOLYN SODIUM. | CROMOLYN SODIUM | 1 | Ophthalmic | 1 DF, 4X/DAY 1 DROP IN AFFECTED EYE 4X/DAY) | 0 | 1 | DF | QID | |||||||
| 120427473 | 12042747 | 30 | C | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, UNK | 0 | 100 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120427473 | 12042747 | 1 | Pulmonary hypertension |
| 120427473 | 12042747 | 2 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120427473 | 12042747 | OT |
| 120427473 | 12042747 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120427473 | 12042747 | Acute respiratory failure | |
| 120427473 | 12042747 | Asthenia | |
| 120427473 | 12042747 | Condition aggravated | |
| 120427473 | 12042747 | Cough | |
| 120427473 | 12042747 | Drug dose omission | |
| 120427473 | 12042747 | Dyspnoea | |
| 120427473 | 12042747 | Dysstasia | |
| 120427473 | 12042747 | Hypoxia | |
| 120427473 | 12042747 | Pneumonia bacterial | |
| 120427473 | 12042747 | Productive cough | |
| 120427473 | 12042747 | Respiratory tract congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120427473 | 12042747 | 14 | 20160120 | 0 |